2023-2024 Regular Session • US Congress Legislature
SB4426: Promising Pathway Act 2.0
Legislative Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
5/23/2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate
Status Information
Current Status
Introduced(5/23/2024)
Chamber
Senate
Committee
Health, Education, Labor, And Pensions(Senate)
Sponsors
Republican: 6
Democrat: 6
Primary Sponsor
Mike Braun
Republican